Literature DB >> 10855692

Comparative analysis of the effects of gonadotropin-releasing hormone agonist on the proliferative activity, apoptosis, and steroidogenesis in cultured porcine granulosa cells at varying stages of follicular growth.

S Takekida1, J Deguchi, T Samoto, H Matsuo, T Maruo.   

Abstract

This study was conducted to analyze comparative effects of gonadropin-releasing hormone (GnRH) agonist on the proliferation, apoptosis, and differentiated function of cultured porcine granulosa cells from varying follicle stages. Comparative analyses of porcine granulosa cells from varying follicle stages to respond to GnRH agonist were performed in terms of proliferating cell nuclear antigen (PCNA) expression, occurrence of apoptosis, and 17beta-estradiol (E2) and progesterone (P) secretion. PCNA expression was examined by the avidin/biotin immunoperoxidase method with a monoclonal antibody to PCNA, and apoptosis was assessed by in situ DNA 3'-end labeling method and DNA fragmentation analysis. E2 and P were measured by radioimmunoassays. The PCNA positive rate of granulosa cells cultured in the presence of GnRH agonist (10(-9) M) was lower compared with that of cells cultured in the absence of GnRH agonist. However, the apoptosis positive rate was higher, and E2 and P secretion by cultured granulosa cells was lower in the presence of GnRH agonist (10(-9) M) compared with that in the absence of GnRH agonist. The inhibitory effect of GnRH agonist on PCNA positive rate of cultured cells was prominent in granulosa cells from small and medium but not from large follicles. By contrast, the inhibitory effect of GnRH agonist on E2 and P secretion by cultured cells was prominent in granulosa cells from large but not small and medium follicles. The stimulatory effect of GnRH agonist on apoptosis positive rate of cultured cells was, however, uniform regardless of the stages of follicular growth. These results demonstrate that GnRH agonist exerts diverse actions on granulosa cells over the course of follicular growth. One downregulates granulosa proliferation in immature follicles as well as steroidogenesis in mature follicles, and the other upregulates apoptosis of granulosa cells regardless of the stages of follicular growth.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10855692     DOI: 10.1385/ENDO:12:1:61

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  38 in total

1.  DTrp6-Pro9-NEt)-luteinising hormone-releasing factor inhibits follicular development in hypophysectomised rats.

Authors:  S Y Ying; R Guillemin
Journal:  Nature       Date:  1979-08-16       Impact factor: 49.962

Review 2.  Clinical applications of gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs.

Authors:  S S Yen
Journal:  Fertil Steril       Date:  1983-03       Impact factor: 7.329

3.  The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization.

Authors:  S L Tan; C Kingsland; S Campbell; C Mills; J Bradfield; N Alexander; J Yovich; H S Jacobs
Journal:  Fertil Steril       Date:  1992-04       Impact factor: 7.329

4.  Incidence of apoptotic bodies in membrana granulosa of the patients participating in an in vitro fertilization program.

Authors:  K Nakahara; H Saito; T Saito; M Ito; N Ohta; N Sakai; N Tezuka; M Hiroi; H Watanabe
Journal:  Fertil Steril       Date:  1997-02       Impact factor: 7.329

5.  Gonadotropin-releasing hormone analogue binds to luteal cells and inhibits progesterone production.

Authors:  R N Clayton; J P Harwood; K J Catt
Journal:  Nature       Date:  1979-11-01       Impact factor: 49.962

6.  Gonadotropin-releasing hormone directly induces apoptotic cell death in the rat ovary: biochemical and in situ detection of deoxyribonucleic acid fragmentation in granulosa cells.

Authors:  H Billig; I Furuta; A J Hsueh
Journal:  Endocrinology       Date:  1994-01       Impact factor: 4.736

7.  Immunohistochemical localization of epidermal growth factor receptor and myc oncogene product in human placenta: implication for trophoblast proliferation and differentiation.

Authors:  T Maruo; M Mochizuki
Journal:  Am J Obstet Gynecol       Date:  1987-03       Impact factor: 8.661

8.  Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies.

Authors:  B A Robbins; D de la Vega; K Ogata; E M Tan; R M Nakamura
Journal:  Arch Pathol Lab Med       Date:  1987-09       Impact factor: 5.534

9.  A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization.

Authors:  G A San Roman; E S Surrey; H L Judd; J F Kerin
Journal:  Fertil Steril       Date:  1992-10       Impact factor: 7.329

10.  Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis.

Authors:  M Filicori; C Flamigni; G E Cognigni; A Falbo; R Arnone; M Capelli; A Pavani; M Mandini; P Calderoni; L Brondelli
Journal:  Fertil Steril       Date:  1996-02       Impact factor: 7.329

View more
  2 in total

1.  Abundant expression of sodium-potassium-activated adenosinetriphosphatase alpha 1 subunit in corpus luteum of porcine ovary.

Authors:  Ahmed Ali Aljonaid; Asomi Sato; Saiko Asahara; Takeshi Maruo
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.925

Review 2.  Gonadotropin-releasing hormone agonist for ovulation trigger - OHSS prevention and use of modified luteal phase support for fresh embryo transfer.

Authors:  Juan Carlos Castillo; Thor Haahr; María Martínez-Moya; Peter Humaidan
Journal:  Ups J Med Sci       Date:  2020-05-04       Impact factor: 2.384

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.